Latest Financials News

KMD Brands has requested a voluntary suspension of its shares on both the NZX and ASX as it finalises a capital raise, refinancing, and its half-year financial results. The suspension aims to maintain market order while key details remain under negotiation.

Bounty Oil & Gas has announced a comprehensive recapitalisation plan including a $4 million capital raise, a 30-for-1 share consolidation, and debt-to-equity conversions aimed at strengthening its balance sheet and funding Queensland oil projects.

Excelsior Capital Limited has announced a further fully franked special dividend of over $10 million amid its ongoing winding up process, alongside key board changes and plans for final capital returns.

AMP Limited has announced a $150 million on-market share buyback set to begin after its first-quarter cashflow release in April 2026, signalling a strategic focus on shareholder returns and organic growth.

DGL Group Limited has replaced its ANZ-led financing with a new $120 million facility from ScotPac, extending maturity and enhancing working capital flexibility amid ongoing management restructuring.

Ramelius Resources has updated its dividend announcement for the six months ending December 2025, confirming a fully franked dividend of 3 cents per share and setting the Dividend Reinvestment Plan issue price at AUD 3.5244.

Sequoia Financial Group has postponed its interim dividend payment to mid-May as it finalises the sale of InterPrac and awaits ASX guidance on a potential shareholder meeting.

Fatfish Group has revealed improper conduct by a former service provider that delayed its 2024 financial reporting, while outlining ongoing legal actions and a strategy to relist on the ASX within four months.

Killi Resources Limited has successfully completed the first tranche of its share placement, issuing over 26 million shares to raise just over $1 million. The company confirms full regulatory compliance with no undisclosed information.

Kjerulf David Hastings Ainsworth has initiated a second unconditional off-market takeover bid for 5.5% of Ainsworth Game Technology shares at a significant premium, aiming to increase his stake and influence in the company.

Lumos Diagnostics has secured a pivotal US FDA CLIA waiver for its FebriDx® test, vastly expanding its market reach and triggering milestone payments that bolster its US commercial rollout.

Lachlan Star has completed its acquisition of a major interest in the New Waverley Gold Project in Western Australia, with a maiden diamond drilling program scheduled to start next week.